Home - Products - Others - Other Targets - 15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one

CAS No. 420781-85-7

15,26-Dihydroxylanosta-7,9(11),24-trien-3-one( —— )

Catalog No. M32555 CAS No. 420781-85-7

The fruit body of Ganoderma lucidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 664 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    15,26-Dihydroxylanosta-7,9(11),24-trien-3-one
  • Note
    Research use only, not for human use.
  • Brief Description
    The fruit body of Ganoderma lucidum.
  • Description
    The fruit body of Ganoderma lucidum.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    420781-85-7
  • Formula Weight
    454.7
  • Molecular Formula
    C30H46O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Rac1 Inhibitor F56, ...

    Control peptide version of Rac1 Inhibitor; comprises residues 45-60 of Rac1 with Trp56 replaced by Phe. Does not affect GEF-Rac1 interaction.

  • PK150

    PK150 shows oral bioavailability and antibacterial activity against several pathogenic strains at submicromolar concentrations.

  • Biotin-(Arg8)-Vasopr...

    Biotinyl-(Arg8)-Vasopressin is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.